Prevest Denpro Share Price
Small Cap | Pharmaceuticals and health care | BSE: 543363
₹472.00 
-1.40 (-0.30 %)
Last Updated: 30 Apr 2025 04:01 PM
BEARISH
Overview
Open (₹) 467.05
High (₹) 472.00
Low (₹) 460.05
Prev. Close (₹) 473.40
Volume 8,200
VWAP (₹) 525.39
ROCE (%) 23.99
Industry P/E 75.76
TTM P/E 31.85
P/B Ratio 6.39
Market Cap (₹) Cr.566.54
Dividend Yield (%)0.21
EPS (₹) 13.45
ROE18.22%
Sales Growth (%) --
Profit Growth (%)--
Day Range
472.00472.00
52 Week Range
351.00686.00
Historical Returns
Returns (6M)
-14.13 %
Returns (1Y)
17.65 %
Returns (3Y)
25.05 %
Returns (5Y)
149.01 %
Returns (6M)
-14.13 %
Returns (1Y)
17.65 %
Returns (3Y)
25.05 %
Returns (5Y)
149.01 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI 52.98
MFI 51.07
ATR 28.67
Commodity Channel Index 124.85
ROC125 -11.08
ROC21 30.84
Williams %R -19.09
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 535.26 | 545.88 | 555.26 | 525.88 | 515.26 | 505.88 | 495.26 |
| Week Ago | 508.66 | 514.33 | 525.66 | 497.33 | 491.66 | 480.33 | 474.66 |
| Month Ago | 414.60 | 420.50 | 431.00 | 404.10 | 398.20 | 387.70 | 381.80 |
EMA & SMA
472.00
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
16
5 Day 514.87
9 Day 507.76
10 Day 499.94
12 Day 481.23
14 Day 483.53
20 Day 472.54
26 Day 459.84
50 Day 470.89
100 Day 526.13
200 Day 555.07
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| RAMLAL KANWARLAL JAIN | bulk | Sell | 9th Feb, 2022 | ₹345.16 | 64,000 | BSE |
| VINOD H BIYANI | bulk | Sell | 31st Jan, 2022 | ₹401.26 | 12,800 | BSE |
| NEXT ORBIT VENTURES FUND | bulk | Sell | 31st Jan, 2022 | ₹391.17 | 1,47,200 | BSE |
| VINOD H BIYANI | bulk | Buy | 31st Jan, 2022 | ₹390.50 | 1,28,000 | BSE |
| RAMLAL KANWARLAL JAIN | bulk | Buy | 3rd Jan, 2022 | ₹454.91 | 72,000 | BSE |
| NEXT ORBIT VENTURES FUND | bulk | Sell | 31st Dec, 2021 | ₹433.75 | 78,400 | BSE |
| NEXT ORBIT VENTURES FUND | bulk | Buy | 31st Dec, 2021 | ₹433.75 | 3,200 | BSE |
| SHAH SHARAD KANAYALAL | bulk | Buy | 9th Dec, 2021 | ₹363.30 | 70,400 | BSE |
| MARUTI NANDAN COLONIZERS PRIVATE LIMITED | bulk | Sell | 11th Oct, 2021 | ₹279.47 | 1,34,400 | BSE |
| EQUITYINTELLIGENCEINDIA PRIVATELIMITED | bulk | Buy | 7th Oct, 2021 | ₹228.91 | 92,800 | BSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 8th Aug, 2024 | Rs.1.0000 per share(10%)Final Dividend | 30th Aug, 2024 | 30th Aug, 2024 |
| 3rd Aug, 2023 | Rs.1.0000 per share(10%)Final Dividend | 23rd Aug, 2023 | 23rd Aug, 2023 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 29th Apr, 2025 | BSE India | <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Prevest Denpro Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85199JK1999PLC001969</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=''float:left;''> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No</div> <br/><br/><br/> <div style=''float:left;''> Name of the Company Secretary: AMAN SADHOTRA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: cs@prevestdenpro.com</div> <div ''style=float:left;margin-left:50px;''> Name of the Chief Financial Officer: NAMRATA MODI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: executivedirector@prevestdenpro.com</div> </div> <div> <br/> Date: 29/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div> |
| 11th Apr, 2025 | BSE India | Enclosed herewith Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended March 31, 2025. |
| 12th Feb, 2025 | BSE India | Integrated filing (financial) for the quarter and nine months ended December 31, 2024. |
| 10th Feb, 2025 | BSE India | Investor Presentation on the Financial Results for the quarter ended on December 31, 2024. |
| 1st Feb, 2025 | BSE India | Intimation of Investment in Axiodent Inc. |
| 1st Feb, 2025 | BSE India | Statement of deviation or variation of funds for the quarter ended on December 31, 2024. |
| 1st Feb, 2025 | BSE India | Considered and approved the unaudited financial results (standalone and consolidated) of the Company for quarter ended on December 31, 2024. |
| 1st Feb, 2025 | BSE India | Considered and approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended on December 31, 2024. |
| 27th Jan, 2025 | BSE India | Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2025 ,inter alia, to consider and approve the un-audited Financial Results of the Company for the quarter ended on December 31, 2024. |
| 22nd Nov, 2024 | BSE India | Transcript of conference call with Investors and Analysts held on November 20, 2024 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 28th Jan, 2025 | 1st Feb, 2025 |
| Half Yearly Results | -- | 5th Nov, 2024 | 11th Nov, 2024 |
| Quarterly Results & Final Dividend | -- | 1st Aug, 2024 | 8th Aug, 2024 |
| Audited Results | (Revised) | 7th May, 2024 | 28th May, 2024 |
| Audited Results | -- | 7th May, 2024 | 10th May, 2024 |
| Quarterly Results | -- | 25th Jan, 2024 | 3rd Feb, 2024 |
| Half Yearly Results | -- | 27th Oct, 2023 | 3rd Nov, 2023 |
| Quarterly Results, Final Dividend & A.G.M. | -- | 28th Jul, 2023 | 3rd Aug, 2023 |
| Audited Results | -- | 20th Apr, 2023 | 27th Apr, 2023 |
| Quarterly Results | -- | 8th Feb, 2023 | 13th Feb, 2023 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Sept, 2021 |
|---|---|---|---|---|---|
| Promoter Group | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% |
| Foreign Institutions + | 0.63% | 0.63% | 0.31% | 0.21% | 4.63% |
| Domestic Institutions + | 1.28% | 0.71% | 0.68% | 0.95% | 4.38% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 24.49% | 25.06% | 25.41% | 25.24% | 17.39% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Prevest Denpro
Prevest Denpro is a Public Limited Listed company incorporated on 05/05/1999 and has its registered office in the State of Jammu & Kashmir, India. Company’s Corporate Identification Number(CIN) is L85199JK1999PLC001969 and registration number is 001969. Currently company belongs to the Industry of Medical Equipment & Accessories. Company’s Total Operating Revenue is Rs. 56.44 Cr. and Equity Capital is Rs. 12.00 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1999
Managing Director
Mr. Atul Modi
NSE Symbol
--
Prevest Denpro Management
| Name | Designation |
|---|---|
| Mr. Atul Modi | Chairman & Managing Director |
| Mrs. Namrata Modi | WholeTime Director & CFO |
| Dr. Sai Kalyan Surapaneni | Executive Director |
| Mr. Vaibhav Munjal | Executive Director |
| Ms. Niharika Modi | Non Executive Director |
| Dr. Nikhil Shrikant Bobade | Independent Director |
| Dr. Sudeep Murthy | Independent Director |
| Mr. Pardeep Gandotra | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Poly Medicure | ₹26,081.24 | ₹2,574.00  ₹2,588.30(-0.55%) | ₹1,565.000 - ₹3,350.000 |
| Tarsons Products | ₹1,925.00 | ₹361.80 ₹371.25(-2.55%) | ₹282.000 - ₹543.800 |
| Borosil Scientific | ₹1,163.96 | ₹130.88  ₹130.65(0.18%) | ₹109.800 - ₹229.800 |
| Vasa Denticity | ₹1,037.61 | ₹624.25 ₹634.00(-1.54%) | ₹480.000 - ₹840.000 |
| Prevest Denpro | ₹566.54 | ₹472.00 ₹473.40(-0.30%) | ₹351.000 - ₹686.000 |
FAQs on Prevest Denpro
What is the share price of Prevest Denpro?
The share price of Prevest Denpro on 30th Apr, 2025 is ₹ 472.00.
What is 52W high and 52W low share price of Prevest Denpro?
The highest and lowest 52W share prices of Prevest Denpro are ₹ 686.000 and ₹ 351.000
What is the market cap of Prevest Denpro?
The market capitalization of Prevest Denpro as of 30th Apr, 2025 is ₹ 566.54 Crores
What is the P/E ratio of Prevest Denpro?
The current P/E ratio of Prevest Denpro as of 30th Apr, 2025 is 75.76
What is the PB ratio of Prevest Denpro?
The PB ratio of Prevest Denpro as of 30th Apr, 2025 is 6.39
Top Gainers
₹78.00
₹65.00 (0.20%)
₹121.03
₹100.86 (0.20%)
₹13.15
₹11.00 (0.20%)
₹1.88
₹1.57 (0.20%)
Top Losers
₹107.95
₹123.00 (-0.12%)
₹0.50
₹0.56 (-0.11%)
₹24.55
₹28.11 (-0.13%)
₹3.34
₹3.80 (-0.12%)
Market Indices
Sensex
₹80,242.24
₹80,288.38 (0.00%)